Alemtuzumab treatment in Multiple Sclerosis: real clinical experience in the Northwest of Spain

被引：0

作者：

Lopez Real, Ana ^{[1
]}

Gonzalez Suarez, Ines ^{[2
]}

Costa Arpin, Eva ^{[3
]}

Pato Pato, Antonio ^{[4
]}

Alvarez Rodriguez, Elena ^{[2
]}

Rodriguez Regal, Ana ^{[5
]}

Garcia-Pelayo Rodriguez, Ana ^{[1
]}

Garcia Bargo, Maria Dolores ^{[6
]}

Llaneza Gonzalez, Miguel ^{[7
]}

Rodriguez Rodriguez, Maria ^{[8
]}

Solar Sanchez, Dulce Maria ^{[9
]}

Oterino Duran, Agustin ^{[10
]}

Pena Martinez, Joaquin ^{[11
]}

机构：

[1] Univ Hosp A Coruna, Neurol, La Coruna, Spain

[2] Univ Hosp Vigo, Neurol, Vigo, Spain

[3] Univ Hosp Santiago De Compostela, Neurol, Santiago De Compostela, Spain

[4] Povisa Hosp Vigo, Neurol, Vigo, Spain

[5] Univ Hosp Pontevedra, Neurol, Pontevedra, Spain

[6] Univ Hosp Ourense, Neurol, Orense, Spain

[7] Univ Hosp Ferrol, Neurol, Ferrol, Spain

[8] Hosp Lucus Augusti, Lugo, Spain

[9] Univ Hosp Cabuenes, Neurol, Gijon, Spain

[10] Univ Hosp Marques Valdecilla, Neurol, Santander, Spain

[11] Univ Hosp San Agustin, Neurol, Aviles, Spain

来源：

NEUROLOGY | 2018年 / 90卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P6.352

引用

页数：3

共 50 条

[31] Observational study on real-life experience with alemtuzumab in naive patients with aggressive Multiple Sclerosis
Moiola, L.
Di Cristinzi, M.
Zanetta, C.
Rinaldi, F.
Brambilla, L.
Annovazzi, P.
Frau, J.
Malucchi, S.
Lanzillo, R.
Lus, G.
Cavalla, P.
Gallo, A.
Barcella, V.
Bucello, S.
Marfia, G.
Totaro, R.
Cerqua, R.
Baldi, E.
Chiveri, L.
Tortorella, C.
Tonietti, S.
Lapucci, C.
Santuccio, G.
Filippi, M.
EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 204 - 204
[32] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
Zmira, Ofir
Halpern, Alex, I
Abraham, Lital
Achiron, Anat
ACTA NEUROLOGICA BELGICA, 2021, 121 (06) : 1513 - 1518
[33] Efficacy and safety of alemtuzumab treatment in a real-world cohort of patients with multiple sclerosis
Ofir Zmira
Alex I. Halpern
Lital Abraham
Anat Achiron
Acta Neurologica Belgica, 2021, 121 : 1513 - 1518
[34] Alemtuzumab for multiple sclerosis
不详
LANCET, 2012, 380 (9856): : 1792 - 1792
[35] Lessons from clinical trials of alemtuzumab in multiple sclerosis
Chaudhuri, Abhijit
Behan, Peter O.
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (02) : 92 - 95
[36] Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects
Kousin-Ezewu, Onajite
Coles, Alasdair
THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2013, 4 (03) : 97 - 103
[37] Alemtuzumab for multiple sclerosis
Riera, Rachel
Porfirio, Gustavo J. M.
Torloni, Maria R.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
[38] Alemtuzumab for Multiple Sclerosis
Mark D. Willis
Neil P. Robertson
Current Neurology and Neuroscience Reports, 2016, 16
[39] Alemtuzumab for multiple sclerosis
Riera, Rachel
Torloni, Maria Regina
Martimbianco, Ana Luiza C.
Pacheco, Rafael L.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (06):
[40] Alemtuzumab in Multiple Sclerosis
Azzopardi, Laura
Coles, Alasdair
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2011, 48 : 79 - 82

← 1 2 3 4 5 →